508 related articles for article (PubMed ID: 26717416)
1. C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.
Shrotriya S; Walsh D; Bennani-Baiti N; Thomas S; Lorton C
PLoS One; 2015; 10(12):e0143080. PubMed ID: 26717416
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
3. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.
Gheytanchi E; Madjd Z; Janani L; Rasti A; Ghods R; Atyabi F; Asadi-Lari MH; Babashah S
Syst Rev; 2017 Nov; 6(1):228. PubMed ID: 29149908
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic importance of plasma C-reactive protein (CRP) in oncology].
Deme D; Telekes A
Orv Hetil; 2017 Feb; 158(7):243-256. PubMed ID: 28462626
[TBL] [Abstract][Full Text] [Related]
6. Elevated CRP levels predict poor outcome and tumor recurrence in patients with thymic epithelial tumors: A pro- and retrospective analysis.
Janik S; Bekos C; Hacker P; Raunegger T; Ghanim B; Einwallner E; Beer L; Klepetko W; Müllauer L; Ankersmit HJ; Moser B
Oncotarget; 2017 Jul; 8(29):47090-47102. PubMed ID: 28514756
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of serum C-reactive protein levels in patients with metastatic or locally recurrent gastric cancer.
Chen Z; Sun Y; Wang J; Shen X; Chen L; Zhuang Z
Int J Biol Markers; 2016 Jul; 31(3):e294-9. PubMed ID: 27174235
[TBL] [Abstract][Full Text] [Related]
8. C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis.
Lorton CM; Higgins L; O'Donoghue N; Donohoe C; O'Connell J; Mockler D; Reynolds JV; Walsh D; Lysaght J
Ann Surg Oncol; 2022 Mar; 29(3):1853-1865. PubMed ID: 34773194
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of C-reactive protein in gastric cancer: a meta-analysis.
Yu Q; Yu XF; Zhang SD; Wang HH; Wang HY; Teng LS
Asian Pac J Cancer Prev; 2013; 14(10):5735-40. PubMed ID: 24289571
[TBL] [Abstract][Full Text] [Related]
10. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
11. C-reactive Protein Is a Predictor of Prognosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
Liao DW; Hu X; Wang Y; Yang ZQ; Li X
Ann Clin Lab Sci; 2020 Mar; 50(2):161-171. PubMed ID: 32366552
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma.
Nakanishi H; Araki N; Kudawara I; Kuratsu S; Matsumine A; Mano M; Naka N; Myoui A; Ueda T; Yoshikawa H
Int J Cancer; 2002 May; 99(2):167-70. PubMed ID: 11979429
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis.
Zheng TL; Cao K; Liang C; Zhang K; Guo HZ; Li DP; Zhao S
Asian Pac J Cancer Prev; 2014; 15(19):8075-81. PubMed ID: 25338987
[TBL] [Abstract][Full Text] [Related]
15. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
[TBL] [Abstract][Full Text] [Related]
16. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
[TBL] [Abstract][Full Text] [Related]
17. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review.
Pathak S; Nunes QM; Daniels IR; Smart NJ
Colorectal Dis; 2014 Oct; 16(10):769-76. PubMed ID: 25039573
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein in liver cancer surgery.
Morris-Stiff G; Gomez D; Prasad KR
Eur J Surg Oncol; 2008 Jul; 34(7):727-9. PubMed ID: 18356004
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
